RP
TMO icon

Riverwater Partners’s Thermo Fisher Scientific TMO Stock Holding History

Riverwater Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Sell
836
-1,529
-65% -$734K 0.12% 148
2026
Q1 		$1.16M Buy
2,365
+57
+2% +$30.9K 0.39% 82
2025
Q4 		$1.34M Buy
2,308
+106
+5% +$59.9K 0.52% 66
2025
Q3 		$1.07M Buy
2,202
+275
+14% +$128K 0.44% 68
2025
Q2 		$781K Buy
1,927
+267
+16% +$112K 0.37% 87
2025
Q1 		$826K Sell
1,660
-152
-8% -$82.3K 0.42% 74
2024
Q4 		$943K Buy
1,812
+91
+5% +$50K 0.46% 64
2024
Q3 		$1.05M Sell
1,721
-27
-2% -$16K 0.52% 60
2024
Q2 		$967K Sell
1,748
-28
-2% -$16K 0.72% 35
2024
Q1 		$1.03M Sell
1,776
-17
-0.9% -$9.54K 0.76% 27
2023
Q4 		$952K Buy
1,793
+14
+0.8% +$6.78K 0.75% 28
2023
Q3 		$900K Sell
1,779
-12
-0.7% -$6.39K 0.82% 28
2023
Q2 		$934K Sell
1,791
-13
-0.7% -$7.01K 0.83% 29
2023
Q1 		$1.04M Sell
1,804
-551
-23% -$311K 0.95% 22
2022
Q4 		$1.3M Buy
2,355
+111
+5% +$58.8K 1.11% 19
2022
Q3 		$1.14M Buy
2,244
+157
+8% +$87.9K 1.14% 15
2022
Q2 		$1.13M Buy
2,087
+1,085
+108% +$597K 1.14% 11
2022
Q1 		$592K Sell
1,002
-1,156
-54% -$664K 0.98% 43
2021
Q4 		$1.44M Buy
+2,158
New +$1.35M 1.28% 9

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Riverwater Partners's TMO Position: Q2 2026 in Review

Riverwater Partners reduced its Thermo Fisher Scientific (TMO) stake by 65% in Q2 2026, selling an estimated $734K and leaving 836 shares worth $419K. The position accounts for 0.12% of the portfolio, ranked #148.

Riverwater Partners first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.44M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Riverwater Partners held 836 shares of Thermo Fisher Scientific worth $419K as of Q2 2026.
  • Riverwater Partners sold 1,529 Thermo Fisher Scientific shares in Q2 2026, an estimated $734K.
  • Thermo Fisher Scientific made up 0.12% of Riverwater Partners's portfolio in Q2 2026, its #148 holding.
  • Riverwater Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Riverwater Partners's Thermo Fisher Scientific position peaked at $1.44M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.